文献速递睡眠呼吸障碍

ERS声明:1至23月龄儿童阻塞性睡眠呼吸障碍

ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children.
PubMed 文献 · Eur Respir J · 2017-12-07

欧洲呼吸学会工作组系统检索文献并汇总159篇文章,形成1-23月龄儿童阻塞性睡眠呼吸障碍诊治声明。SDB疑似基于上气道梗阻相关症状或异常,应客观评估严重度(首选多导睡眠监测)。治疗包括腺样体扁桃体切除术、持续气道正压通气及针对特定病因的干预。

要点

  • 1-23月龄儿童SDB疑似基于上气道梗阻相关症状或异常。
  • 严重度应客观评估,首选多导睡眠监测,也可用便携监测或夜间血氧。
  • 腺样体扁桃体切除术和CPAP是最常用治疗,同时针对特定病因干预。

核心结论

  • 1-23月龄儿童阻塞性睡眠呼吸障碍是多因素疾病,需客观评估并治疗所有导致睡眠上气道梗阻的潜在异常。

研究设计与样本

  • 欧洲呼吸学会工作组制作声明,系统文献检索后汇总159篇文章回答临床相关问题。

主要发现

  • SDB疑似基于上气道梗阻相关症状或异常;可伴有肺高压、生长迟缓、行为问题及喂养困难、复发性中耳炎等。
  • SDB严重度应客观测量,首选多导睡眠监测,也可用便携监测或夜间血氧。
  • 腺样体扁桃体切除术和持续气道正压通气是最常用治疗措施。

关键数值与推荐

  • 清醒时明显上气道梗阻、睡眠检查异常合并SDB症状(如打鼾)和/或易患SDB条件(如下颌发育不全)的儿童可从治疗中获益。
  • SDB合并复杂疾病(如唐氏综合征、Prader-Willi综合征)的儿童可从治疗中获益。
  • 针对特定情况的干预包括喉软化行声门上成形术、下颌发育不全行鼻咽气道。

临床怎么用

  • 对1-23月龄疑似SDB儿童,应客观评估严重度并治疗所有导致睡眠上气道梗阻的潜在异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The present statement was produced by a European Respiratory Society Task Force to summarise the evidence and current practice on the diagnosis and management of obstructive sleep disordered breathing (SDB) in children aged 1-23 months. A systematic literature search was completed and 159 articles were summarised to answer clinically relevant questions. SDB is suspected when symptoms or abnormalities related to upper airway obstruction are identified. Morbidity (pulmonary hypertension, growth delay, behavioural problems) and coexisting conditions (feeding difficulties, recurrent otitis media) may be present. SDB severity is measured objectively, preferably by polysomnography, or alternatively polygraphy or nocturnal oximetry. Children with apparent upper airway obstruction during wakefulness, those with abnormal sleep study in combination with SDB symptoms (e.g. snoring) and/or conditions predisposing to SDB (e.g. mandibular hypoplasia) as well as children with SDB and complex conditions (e.g. Down syndrome, Prader-Willi syndrome) will benefit from treatment. Adenotonsillectomy and continuous positive airway pressure are the most frequently used treatment measures along with interventions targeting specific conditions (e.g. supraglottoplasty for laryngomalacia or nasopharyngeal airway for mandibular hypoplasia). Hence, obstructive SDB in children aged 1-23 months is a multifactorial disorder that requires objective assessment and treatment of all underlying abnormalities that contribute to upper airway obstruction during sleep.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kaditis AG, Alonso Alvarez ML, Boudewyns A, et al. ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children. Eur Respir J. 2017. PMID: 29217599. doi:10.1183/13993003.00985-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。